PAHC

PHIBRO ANIMAL HEALTH CORP

PAHC·71742Q106·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

PAHC (PHIBRO ANIMAL HEALTH CORP) is held by 132 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($180M), FMR LLC ($120.2M), STATE STREET CORP ($52.5M). Net institutional sentiment: Mixed.

132
Holders
Avg rating(26 Elite)
$875.3M
Total Value
63% (139)
Fund Consensus
84 buying - 49 selling
PAHCSmart Money Verdict
View all
Held by 132 funds
26 elite
Who's Trading
ActivistBFBFI Co., LLC48.2%May 22, 2026
ActivistBarclays PLCBarclays PLC1.3%May 14, 2026
InsiderBJBENDHEIM JACKSell $64KMay 7, 2026
InsiderBJBENDHEIM JACKSell $56KMay 7, 2026
InsiderBJBENDHEIM JACKSell $100KMay 7, 2026
InsiderBJBENDHEIM JACKSell $322KMay 6, 2026
InsiderBJBENDHEIM JACKSell $82KMay 6, 2026
InsiderBJBENDHEIM JACKSell $349KMay 5, 2026
InsiderBJBENDHEIM JACKSell $44KMay 5, 2026
InsiderBJBENDHEIM JACKSell $306KApr 30, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
3.3M(-2.7%)$180M0.0%+55.38%
0
Increased
2.2M(+215.6%)$120.2M0.0%-32.50%
49
Increased
950,033(+0.8%)$52.5M0.0%+143.59%
29
New
891,283$49.3M0.0%-38.65%
41
Increased
604,648(+6.2%)$33.4M0.0%+30.03%
31
Increased
576,735(+5.8%)$31.9M0.0%+47.15%
31
Increased
507,852(+3.1%)$28.1M0.0%+110.67%
30
New
490,342$27.1M0.0%-38.65%
40
Increased
455,891(+2.6%)$25.2M0.0%+41.10%
29
Decreased
391,187(-12.6%)$21.6M0.0%+79.15%
0
Increased
330,977(+28.2%)$18.3M0.0%+10.24%
35
Increased
286,172(+145.6%)$15.7M0.0%-31.59%
45
Decreased
264,262(-1.6%)$14.6M0.0%+51.92%
0
Decreased
229,991(-0.9%)$12.7M0.0%+89.72%
0
Increased
219,401(+2.9%)$12.1M0.0%+20.90%
29
Decreased
208,449(-28.6%)$11.5M0.0%+14.07%
0
Increased
193,436(+7.8%)$10.7M0.0%+27.83%
30
Increased
176,200(+9.5%)$9.7M0.0%+21.21%
30
Decreased
176,675(-34.9%)$9.4M0.0%-15.56%
0
Decreased
160,567(-2.8%)$8.9M0.0%+105.60%
0

Showing 1-20 of 139

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used